Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL962124 | 0.98 | MEN1 (0.47) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL413382 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL409128 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL898377 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL899147 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL5291584 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL5287687 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL5288768 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL5302535 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A | |
| SCHEMBL412673 | 0.98 | ABCB11 (0.48) | ABCB11ESR1PGRCHRM2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9267214-B2 | Aluminum recovery process | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2016-02-23 | — | — | US | claimed |
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20110000782-A1 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2011-01-06 | — | — | US | claimed |
| US-RE48165-E1 | Alkenyl (perfluoroalkyl) phosphinic acids | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| WO-2020152206-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2020-07-30 | — | — | WO | disclosed |
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | MERCK PATENT GMBH (DE) | 2018-12-25 | — | — | US | disclosed |
| EP-3207047-B1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | MERCK PATENT GMBH (DE) | 2018-09-12 | — | — | EP | disclosed |
| US-20180219257-A1 | ALUMINUM-ION BATTERY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2018-08-02 | — | — | US | disclosed |
| US-20170240574-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACIDS | MERCK PATENT GMBH (DE) | 2017-08-24 | — | — | US | disclosed |
| EP-3207047-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACID | Merck Patent GmbH (DE) | 2017-08-23 | — | — | EP | disclosed |
| US-20110000782-A1 | ALUMINUM RECOVERY PROCESS | THE UNIVERSITY OF ALABAMA (US) | 2011-01-06 | — | — | US | disclosed |
| WO-2010069458-A1 | HEXAHALOCHROMATE (LLL) COMPLEXES | MERCK PATENT GMBH (DE) | 2010-06-24 | — | — | WO | disclosed |
| US-20100099031-A1 | NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2166611-A1 | NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-03-24 | — | — | EP | disclosed |
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2067770-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | Wako Pure Chemical Industries, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | SULT1A1, SULT2A1, STS | ABCB11 303/4885ESR1 2207/4885PGR 4473/4885 |
| US-10160777-B2 | Alkenyl(perfluoroalkyl)phosphinic acids | PHOSPHO1, PFAS, SLCO4C1 | ABCB11 347/4885ESR1 1152/4885PGR 1787/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | ABCB11 964/4885ESR1 1760/4885PGR 4652/4885 |
| US-20170240574-A1 | ALKENYL (PERFLUOROALKYL) PHOSPHINIC ACIDS | PHOSPHO1, PFAS, SLCO4C1 | ABCB11 347/4885ESR1 1152/4885PGR 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.